INTRODUCTION
A major problem in drug discovery is that water solubility of 40% of the new drug molecule is very low resulting inadequate bioavailability, high intrasubject/intersubject changeability and dose proportionality deficiency coupled with elevated hydrophobicity which obstructs the oral delivery of several drugs (Lipinski, 2002; Palmer, 2003) . Consequently, it is essential to construct satisfactory formulations which are truly crucial to enhance the solubility and bioavailability of such drugs (Debnath et al., 2011) . Self-emulsifying drug delivery systems is one of the most recognized and economically feasible formulation concepts for solving these measures. In advancing the oral bioavailability of poorly water-soluble and lipophilic drugs, SEDDS have been adduced to be sensibly outstanding (Gursoy and Benita, 2004) . It is well diagnosed that lipid-based formulations can elevate oral bioavailability of insufficiently water-soluble drugs (Pouton, 2000) .
SEDDS are isotropic mixture of oil(s), surfactant(s), co-surfactant(s), co-solvent(s) and drug. They form fine oil-in-water emulsions when introduced into aqueous media under gentle agitation (Constantinides, 1995) . The aptitude of SEDDS for enhancing the bioavailability of poorly soluble drugs has been assured for at least a decade (Charman et al., 1992) . Notwithstanding, major drawbacks of SE formulations are elevated production costs, poor solubility and portability, inadequate drug loading and fewer options of dosage forms as SE formulations are typically formulated as liquids (Tang et al., 2008 ) .
There are plenty of arrangements of lipid formulations such as emulsions, surfactant dispersions, oils, solid lipid nanoparticles, liposomes and most importantly SEDDS as it is associated with lipidbased formulations. SEDDS includes the complex
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blends of surfactant and/or co-surfactant, oil/lipid and isotropic combination of drugs as a result emulsion/lipid droplets of close to 100nm (SEDDS) to less than 50nm for self-micro emulsifying drug delivery systems (SMEDDS), on dilution with physiological fluid are constituted (Tang et al.,2008) . Accordingly, the absorption rate of hydrophobic drugs from the crystalline state becomes limited due to the drug persists in solution form in the gastrointestinal gut escaping the dissolution step (Hauss, 2007) . The lipid based formulation strategy has magnetized vast appeal toward amplifying drug solubilisation in the GI tract and to advance the oral bioavailability of BCS Class II and IV drugs (Baboota et al., 2007; Amidon et al., 1995) .
The mechanism of action of Self-emulsification is still unsettled. Nevertheless, as stated in Reiss (Reiss, 1975) , as soon as the entropy change that accommodates dispersion is outstanding than the energy desired to step up the surface area of the dispersion, self-emulsification takes place. Besides, to introduce a surface between the two phases the energy needed is functionally coupled with the free energy of a classical emulsion formation and these can be characterized by the equation-
Where ΔG stands for free energy connected with the process, N represents the number of droplets of radius, r, and σ indicates the interfacial energy.
Non-steroidal anti-inflammatory drug (NSAID), Ibuprofen has been extensively administered for mild to moderate pain. A primary requirement for rapid onset of action of Ibuprofen is its express absorption as serum concentrations and analgesic effect of Ibuprofen are interlinked. Nevertheless, following oral administration bioavailability of Ibuprofen is comparatively poor by reason of insolubility in water (Ghorab and Adeyeye, 1994; Glowka, 2000) .
MATERIALS AND METHODS

Materials
Pure drug sample of ibuprofen was procured from Xamim, China. Capmul PG8 was procured from Abitec Corporation, Germany and Cremophor EL was procured from BASF, Germany. All other ingredients were obtained commercially and used as received.
Preparation of Calibration Curve of Ibuprofen 20mg of Ibuprofen was taken in a 1000ml volumetric flask and diluted with phosphate buffer (pH 7.2) up to 1000 ml. This solution was labeled as stock solution. From the stock solution, 1ml, 2ml, 3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 9ml, 10ml was withdrawn with volumetric pipettes, each time the withdrawn solution was taken in different volumetric flask (10ml) and the volume of each of the solution was made up to 10ml with phosphate buffer. The absorbances of the solutions were measured by a UV-VIS spectrophotometer of Shimadzu at 221nm. Using the method, a linear relation (y=0.0419x+0.0308) was obtained between Ibuprofen concentration (μg/ml) and absorbance values. Correlation Co-efficient (R 2 ) value of the calibration curve was found 0.9997.
Solubility analysis of Ibuprofen in various excipients
Solubility of Ibuprofen in various components (Capmul PG8 and Cremophor EL) was studied. 1ml of each of the vehicles was added to each captube containing Ibuprofen (300mg). After sealing, mixing of the systems were performed using sonicator and vortex mixer accordingly. Then the mixtures were heated at ≤40°C in a water bath to facilitate the solubilization and to create clear transparent solution. The mixtures were then kept at room 
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temperature for 48 hours. After 48 hours, observed the clear solutions were still maintained.
Preparation of SEDDS formulation of Ibuprofen SEDDS formulations were developed using Capmul PG8 as oil phase and Cremophor EL as surfactant. Then a series of SEDDS formulation of Ibuprofen were prepared using formulation system ( Table 2) . Accurately weighed Ibuprofen was placed in a glass vial and Capmul PG8, Cremophor EL were added. Then the components were mixed by gentle vortexing and were heated at ≤40°C until Ibuprofen was properly dissolved. The SEDDS formulas in the glass vials were then kept at room temperature until further use. 10 mg equivalent weights of Ibuprofen were taken in each 2 size capsule shell and capsules were sealed.
In-vitro Dissolution Study of Ibuprofen SEDDS
The dissolution studies were carried out using a ‚USP Dissolution Apparatus 2 (Paddle type)‛ Phosphate buffer (pH 7.2) was used as dissolution media, rpm of baskets paddles were 50 rpm and temperature of dissolution media was maintained at 37±0.5°C. One capsule shell was placed into each of one basket with a sinker; these were inserted in the vessels. Dissolution samples were withdrawn at predetermined time intervals of 5, 10, 15, 20, 25, 30, 45, 60 
Response surface methodology
Many statistical experimental designs have been recognized as useful technique to optimize the process variables. For this purpose, a computer based optimization technique with response surface methodology (RSM) using a polynomial equation has been widely used. Different types of RSM design include 3-level factorial design, Box-Behnken design and D-optimal design. Based on the principal of design of experiments (DoE), the methodology encompasses the use of various types of experimental designs, generation of polynomial equations, and mapping of the response over the experimental domain to determine the optimum formulation. Response Surface Methodology (RSM) is used only when a few significant factors are involved in 
Chemicals (mg) F1 F2 F3 F4 F5 F6 F7 F8 F9
Ibuprofen 100 100 100 100 100 100 100 100 100 Capmul PG8 100 100 100 300 300 300 500 500 500 Cremophor EL 900 500 700 900 500 700 900 500 700 A 3-level factorial design was employed as per the standard protocol. The amounts of Capmul PG8 (X1) and Cremophor EL (X2) were selected as dependant variables, studied at 3 levels each. The central point (0,0) was studied in quintuplicate. All other formulation and processing variables were kept invariant throughout the study. Total 13 experimental runs were conduced. Responses considered are Y1-Drug releases at 5 minute, Y2-Drug release at 15 minute, Y3-Drug release at 45 minute were taken as the response variables.
Optimization of Data Analysis
Various RSM computations for the current optimization study were performed employing Design Expert software (Design Expert 8.0.3.1 Trial Version, Stat-Ease Inc, Minneapolis, MN). Polynomial models including interaction and quadratic terms were generated for all the response variables using multiple linear regression analysis (MLRA) approach. The general form of the MLRA model is represented as equation:
Where, A 0 is the intercept representing the arithmetic average of all quantitative outcomes of 13 runs; A 1 to A 5 are the coefficients computed from the observed experimental values of Y; and X 1 and X 2 are the coded levels of the independent variable(s). The terms X 1 X 2 and X 1 (i = 1 to 2) represent the interaction and quadratic terms, respectively. Statistical validity of the polynomials was established on the basis of ANOVA provision in the Design Expert software. Subsequently, the feasibility and grid searches were performed to locate the composition of optimum formulations. Also, the 3-D response surface graphs and 2-D contour plots were constructed in MS-Excel environment using the output files generated by the Design Expert software.
RESULTS AND DISCUSSION
Ibuprofen is a poorly water soluble drug. It was not seemed to be soluble in normal condition, but it was soluble when heated in a steam bath for few minutes. The solubility and the dissolution of Ibuprofen were very slow. But it was made soluble and brought into the dissolution first by the addition of co-solvent (Capmul PG8) and surfactant (Cremophor EL). Drug release kinetics was done by basket method using pH 7.2 phosphate buffer as dissolution medium at room temperature 37±0.5°C at 50 rpm speed. The sample was collected for 1 hour studies and percentage of drug release at different time interval was calculated from the UV absorbance reading.10 ml syringe was used to take 10 ml sample from each sample basket and 10 ml of fresh phosphate buffer was added after the sample was taken into each sample basket. Sample was filtered and percent (%) release of Ibuprofen was calculated from UV absorbance reading of sample.
Percent (%) release for Ibuprofen SEDDS formulation
The formulation ( Cremophor So, it can be considered that the vehicles acted here as emulsifying agents for the liberated drug, thus preventing the formulation of any water insoluble surface layers. Although the liberated drug remained un-dissolved in the dissolution medium when its concentration exceeded its saturation solubility, it was emulsified in a finely divided state because of surface activity of the dissolved vehicle.
Percent (%) release for the formulations which had the fixed amount of Capmul PG8 or Cremophor EL Where the amount of Capmul PG8 was fixed but the amount of Cremophor EL was different
In case of formulation F1, F2, F3 ( Table 4 ) the amount of Capmul PG8 was 10mg but the amount of Cremophor EL were 90mg, 50mg, and 70mg respectively. The combination of drug (10mg), Capmul PG8 (10mg) and Cremophor EL (70mg) showed highest % release that was 31.014% (Figure 4) .
In case of formulation F4, F5, F6 ( Table 5 ) the amount of Capmul PG8 was 30mg but the amount of Cremophor EL were 90mg, 50mg, and 70mg respectively. The combination of drug (10mg), Capmul PG8 (30mg) and Cremophor EL (70mg) showed highest % release that was 94.367% ( Figure 5 ).
In case of formulation F7, F8, F9 ( Table 6 ) the amount of Capmul PG8 was 50mg but the amount of Cremophor EL were 90mg, 50mg, and 70mg respectively. The combination of drug (10mg), Capmul PG8 (50mg) and Cremophor EL (50mg) showed highest % release that was 51.425% (Figure 6 ).
Here we can predict that, co-relation was presented between formulations F3 and F6 but there was no co-relation found formulation F8 with F3 and F6 because there was no sufficient amount of Cremophor EL to react with Capmul PG8 and give sufficient emulsifying effect.
Where the amount of Cremophor EL is fixed but the amount of Capmul PG8 is different
In case of formulation F1, F4, F7 ( Table 7 ) the amount of Cremophor EL was 90mg but the amount of Capmul PG8 were 10mg, 30mg, and 50mg respectively. The combination of drug (10mg), Cremophor EL (90mg) and Capmul PG8 (30mg) showed highest % release that was 44.07% (Figure 7) .
In case of formulation F2,F5 , F8 ( Table 8 ) the amount of Cremophor EL was 50mg but the amount of Capmul PG8 were 10mg,30mg,50mg.The combination of drug (10mg), Cremophor EL (50mg) and Capmul PG8 (30mg) showed height % release that was 78.65% (Figure 8 ).
In case of formulation F3,F6 , F9 ( Table 9 ) the amount of Cremophor EL was 70mg but the amount of Capmul PG8 were 10mg,30mg,50mg.The combination of drug (10mg), Cremophor EL (70mg) and Capmul PG8 (30mg) showed height % release that was 94.367% (Figure 9 ).
Here we can predict that, formulations F4, F5 and F6 showed highest % release when the amount Capmul PG8 was 30 mg. In case of SEDDS if the emulsifying The "Pred R-Squared" of 0.0567 is not as close to the "Adj R-Squared" of 0.8193 as one might normally expect. This may indicate a large block effect or a possible problem with your model and/or data.
Things to consider are model reduction, response tranformation, outliers, etc."Adeq Precision" measures the signal to noise ratio. A ratio greater than 4 is desirable. Your ratio of 8.233 indicates an adequate signal. This model can be used to navigate the design space. 
Response 2 at DR 15
The Model F-value of 14.61 implies the model is significant. There is only a 0.14% chance that a "Model F-Value" this large could occur due to noise.Values of "Prob > F" less than 0.0500 indicate model terms are significant.In this case A 2 are The "Pred R-Squared" of 0.2241 is not as close to the "Adj R-Squared" of 0.8501 as one might normally expect. This may indicate a large block effect or a possible problem with your model and/or data.
Things to consider are model reduction, response tranformation, outliers, etc. "Adeq Precision" measures the signal to noise ratio. A ratio greater than 4 is desirable. Your ratio of 8.871 indicates an 
CONCLUSION
The study was designed to optimize Self- 
